sur Curaleaf Holdings, Inc.
Curaleaf Appoints Torsten Greif to Board of Directors
On May 1, 2026, Curaleaf Holdings, Inc., a prominent international cannabis provider, announced the appointment of Torsten Greif to their Board of Directors. Greif is respected as a founder of Four 20 Pharma GmbH, Curaleaf’s significant German brand. His expertise in cannabis cultivation and regulatory strategy has been key in positioning Four 20 Pharma as a leader in Germany's medical cannabis market.
Curaleaf’s CEO Boris Jordan highlighted Greif's strategic vision and local knowledge as vital assets for expanding Curaleaf’s European operations. Greif expressed honor at joining Curaleaf during its international expansion phase, emphasizing the rapidly evolving European cannabis market.
This appointment underscores Curaleaf’s commitment to strategic leadership as the company integrates its European presence and aims for long-term growth.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Curaleaf Holdings, Inc.